Skip to main content
Erschienen in: Osteoporosis International 5/2016

11.12.2015 | Original Article

Soluble CD14 and fracture risk

verfasst von: M. Bethel, P. Bůžková, H. A. Fink, J. A. Robbins, J. A. Cauley, J. Lee, J. I. Barzilay, D. I. Jalal, L. D. Carbone

Erschienen in: Osteoporosis International | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Summary

Soluble CD14 (sCD14) is an inflammatory marker associated with osteoclasts. Using Cox proportional hazards models, we found a positive association between plasma levels of sCD14 and risk of incident fracture among participants in the Cardiovascular Health Study. sCD14 may be useful in identifying those at risk for fracture.

Introduction

Soluble CD14, a proinflammatory cytokine, is primarily derived from macrophages/monocytes that can differentiate into osteoclasts. The purpose of this study was to examine the relationship between sCD14 levels and osteoporotic fractures.

Methods

In the Cardiovascular Health Study, 5462 men and women had sCD14 levels measured at baseline. Incident hip fractures (median follow-up time 12.5 years) and incident composite fractures (defined as the first hip, pelvis, humerus, or distal radius fracture, median follow-up 8.6 years) were identified from hospital discharge summaries and/or Medicare claims data. Cox proportional hazards models were used to model the association between sCD14 levels and time to incident hip or composite fracture, overall and as a function of race and gender.

Results

In unadjusted models, there was a positive association between sCD14 levels (per 1 standard deviation increase, i.e., 361.6 ng/mL) and incident hip (HR, 1.26; 95 % CI, 1.17, 1.36) and composite (HR, 1.20; 95 % CI, 1.12, 1.28) fractures. When models were fully adjusted for demographics, lifestyle factors, and medication use, these associations were no longer significant. However, in whites, the association of sCD14 levels with hip fractures remained significant in fully adjusted models (HR, 1.11; 95 % CI, 1.01–1.23). Associations of sCD14 levels with hip and composite fracture did not differ between men and women.

Conclusions

In this large cohort of community-dwelling older adults, higher sCD14 levels were associated with an increased risk of incident hip fractures in whites.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cauley JA, Danielson ME, Boudreau RM, Forrest KYZ, Zmuda JM, Pahor M et al (2007) Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study. J Bone Miner Res 22(7):1088–1095CrossRefPubMed Cauley JA, Danielson ME, Boudreau RM, Forrest KYZ, Zmuda JM, Pahor M et al (2007) Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study. J Bone Miner Res 22(7):1088–1095CrossRefPubMed
2.
Zurück zum Zitat Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC et al (2012) Inflammatory markers and the risk of hip fracture: the women’s health initiative. J Bone Miner Res 27(5):1167–1176CrossRefPubMedPubMedCentral Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC et al (2012) Inflammatory markers and the risk of hip fracture: the women’s health initiative. J Bone Miner Res 27(5):1167–1176CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Ishii S, Cauley JA, Greendale GA, Crandall CJ, Danielson ME, Ouchi Y et al (2013) C‐Reactive protein, bone strength, and nine‐year fracture risk: data from the study of Women’s Health Across the Nation (SWAN). J Bone Miner Res 28(7):1688–1698CrossRefPubMed Ishii S, Cauley JA, Greendale GA, Crandall CJ, Danielson ME, Ouchi Y et al (2013) C‐Reactive protein, bone strength, and nine‐year fracture risk: data from the study of Women’s Health Across the Nation (SWAN). J Bone Miner Res 28(7):1688–1698CrossRefPubMed
4.
Zurück zum Zitat Feairheller DL, Park JY, Sturgeon KM, Williamson ST, Diaz KM, Veerabhadrappa P et al (2011) Racial differences in oxidative stress and inflammation: in vitro and in vivo. Clin Transl Sci 4(1):32–37CrossRefPubMedPubMedCentral Feairheller DL, Park JY, Sturgeon KM, Williamson ST, Diaz KM, Veerabhadrappa P et al (2011) Racial differences in oxidative stress and inflammation: in vitro and in vivo. Clin Transl Sci 4(1):32–37CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Paalani M, Lee JW, Haddad E, Tonstad S (2011) Determinants of inflammatory markers in a bi-ethnic population. Ethn Dis 21(2):142PubMedPubMedCentral Paalani M, Lee JW, Haddad E, Tonstad S (2011) Determinants of inflammatory markers in a bi-ethnic population. Ethn Dis 21(2):142PubMedPubMedCentral
6.
Zurück zum Zitat Park N-J, Kang D-H (eds) (2013) Inflammatory cytokine levels and breast cancer risk factors: racial differences of healthy Caucasian and African American women. Onc Nurs Soc Park N-J, Kang D-H (eds) (2013) Inflammatory cytokine levels and breast cancer risk factors: racial differences of healthy Caucasian and African American women. Onc Nurs Soc
7.
Zurück zum Zitat Veeranna V, Zalawadiya SK, Niraj A, Kumar A, Ference B, Afonso L (2013) Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: results from a multi-ethnic cohort. Int J Cardiol 166(2):487–493CrossRefPubMed Veeranna V, Zalawadiya SK, Niraj A, Kumar A, Ference B, Afonso L (2013) Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: results from a multi-ethnic cohort. Int J Cardiol 166(2):487–493CrossRefPubMed
8.
Zurück zum Zitat Morimoto Y, Conroy SM, Ollberding NJ, Kim Y, Lim U, Cooney RV et al (2014) Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort. Int J Obes 38(11):1416–1422CrossRef Morimoto Y, Conroy SM, Ollberding NJ, Kim Y, Lim U, Cooney RV et al (2014) Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort. Int J Obes 38(11):1416–1422CrossRef
9.
Zurück zum Zitat Nazmi A, Victora CG (2007) Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7(1):212CrossRefPubMedPubMedCentral Nazmi A, Victora CG (2007) Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7(1):212CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA (1990) Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health 80(7):871–873CrossRefPubMedPubMedCentral Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA (1990) Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health 80(7):871–873CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bohannon AD (1999) Osteoporosis and African American women. J Womens Health Gend Based Med 8(5):609CrossRefPubMed Bohannon AD (1999) Osteoporosis and African American women. J Womens Health Gend Based Med 8(5):609CrossRefPubMed
12.
Zurück zum Zitat Burge R, Dawson‐Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis‐related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475CrossRefPubMed Burge R, Dawson‐Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis‐related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475CrossRefPubMed
13.
Zurück zum Zitat Meuleman P, Steyaert S, Libbrecht L, Couvent S, Van Houtte F, Clinckspoor F et al (2006) Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection. Clin Chim Acta 366(1):156–162CrossRefPubMed Meuleman P, Steyaert S, Libbrecht L, Couvent S, Van Houtte F, Clinckspoor F et al (2006) Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection. Clin Chim Acta 366(1):156–162CrossRefPubMed
14.
Zurück zum Zitat Bažil V, Baudyš M, Hilgert I, Štefanová I, Low MG, Zbrožek J et al (1989) Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD 14. Mol Immunol 26(7):657CrossRefPubMed Bažil V, Baudyš M, Hilgert I, Štefanová I, Low MG, Zbrožek J et al (1989) Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD 14. Mol Immunol 26(7):657CrossRefPubMed
15.
Zurück zum Zitat Massey HM, Flanagan AM (1999) Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106(1):167CrossRefPubMed Massey HM, Flanagan AM (1999) Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106(1):167CrossRefPubMed
16.
Zurück zum Zitat Sørensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, Dziegiel MH et al (2007) Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 25(1):36–45CrossRefPubMed Sørensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, Dziegiel MH et al (2007) Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 25(1):36–45CrossRefPubMed
17.
Zurück zum Zitat Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ et al (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci 99(2):133CrossRefPubMed Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ et al (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci 99(2):133CrossRefPubMed
18.
Zurück zum Zitat Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute-phase protein. J Immunol 172(7):4470–4479CrossRefPubMed Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute-phase protein. J Immunol 172(7):4470–4479CrossRefPubMed
19.
Zurück zum Zitat Zhang J, Fu Q, Ren Z, Wang Y, Wang C, Shen T, et al (2014) Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis. Gynecol Endocrinol 1–8 Zhang J, Fu Q, Ren Z, Wang Y, Wang C, Shen T, et al (2014) Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis. Gynecol Endocrinol 1–8
20.
Zurück zum Zitat Eriksson AL, Movérare‐Skrtic S, Ljunggren Ö, Karlsson M, Mellström D, Ohlsson C (2014) High‐sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study. J Bone Miner Res 29(2):418–423CrossRefPubMedPubMedCentral Eriksson AL, Movérare‐Skrtic S, Ljunggren Ö, Karlsson M, Mellström D, Ohlsson C (2014) High‐sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study. J Bone Miner Res 29(2):418–423CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA et al (1991) The cardiovascular health study: design and rationale. Ann Epidemiol 1(3):263–276CrossRefPubMed Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA et al (1991) The cardiovascular health study: design and rationale. Ann Epidemiol 1(3):263–276CrossRefPubMed
22.
Zurück zum Zitat Reiner AP, Lange EM, Jenny NS, Chaves PH, Ellis J, Li J et al (2013) Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol 33(1):158CrossRefPubMed Reiner AP, Lange EM, Jenny NS, Chaves PH, Ellis J, Li J et al (2013) Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol 33(1):158CrossRefPubMed
23.
Zurück zum Zitat Nicu EA, Laine ML, Morré SA, Van der Velden U, Loos BG (2009) Soluble CD14 in periodontitis. Innate Immun 15(2):121–128CrossRefPubMed Nicu EA, Laine ML, Morré SA, Van der Velden U, Loos BG (2009) Soluble CD14 in periodontitis. Innate Immun 15(2):121–128CrossRefPubMed
24.
Zurück zum Zitat Mikuls TR, LeVan TD, Sayles H, Yu F, Caplan L, Cannon GW et al (2011) Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis. J Rheumatol 38(12):2509–2516CrossRefPubMed Mikuls TR, LeVan TD, Sayles H, Yu F, Caplan L, Cannon GW et al (2011) Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis. J Rheumatol 38(12):2509–2516CrossRefPubMed
25.
Zurück zum Zitat Raj DSC, Carrero JJ, Shah VO, Qureshi AR, Bárány P, Heimbürger O et al (2009) Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis 54(6):1072CrossRefPubMedPubMedCentral Raj DSC, Carrero JJ, Shah VO, Qureshi AR, Bárány P, Heimbürger O et al (2009) Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis 54(6):1072CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W (2003) CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 88(4):1780–1784CrossRefPubMed Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W (2003) CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 88(4):1780–1784CrossRefPubMed
27.
Zurück zum Zitat Valiathan R, Miguez MJ, Patel B, Arheart KL, Asthana D (2014) Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS One 9(5):e97698CrossRefPubMedPubMedCentral Valiathan R, Miguez MJ, Patel B, Arheart KL, Asthana D (2014) Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS One 9(5):e97698CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Frank J, Witte K, Schrödl W, Schütt C (2004) Chronic alcoholism causes deleterious conditioning of innate immunity. Alcohol Alcohol 39(5):386–392CrossRefPubMed Frank J, Witte K, Schrödl W, Schütt C (2004) Chronic alcoholism causes deleterious conditioning of innate immunity. Alcohol Alcohol 39(5):386–392CrossRefPubMed
29.
Zurück zum Zitat Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ, et al (2015) Kidney dysfunction and markers of inflammation in the multicenter AIDS cohort study. J Infect Dis jiv159 Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ, et al (2015) Kidney dysfunction and markers of inflammation in the multicenter AIDS cohort study. J Infect Dis jiv159
30.
Zurück zum Zitat Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M et al (2009) Physical activity and rapid decline in kidney function among older adults. Arch Intern Med 169(22):2116–2123CrossRefPubMedPubMedCentral Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M et al (2009) Physical activity and rapid decline in kidney function among older adults. Arch Intern Med 169(22):2116–2123CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Wilczynski C, Camacho P (2014) Calcium use in the management of osteoporosis: continuing questions and controversies. Curr Osteoporos Rep 12(4):396–402CrossRefPubMed Wilczynski C, Camacho P (2014) Calcium use in the management of osteoporosis: continuing questions and controversies. Curr Osteoporos Rep 12(4):396–402CrossRefPubMed
32.
Zurück zum Zitat Carmeliet G, Dermauw V, Bouillon R (2015) Vitamin D signaling in calcium and bone homeostasis: a delicate balance. Best Pract Res Clin Endocrinol Metab 29(4):621–631CrossRefPubMed Carmeliet G, Dermauw V, Bouillon R (2015) Vitamin D signaling in calcium and bone homeostasis: a delicate balance. Best Pract Res Clin Endocrinol Metab 29(4):621–631CrossRefPubMed
33.
Zurück zum Zitat Leavy B, Byberg L, Michaelsson K, Melhus H, Aberg AC (2015) The fall descriptions and health characteristics of older adults with hip fracture: a mixed methods study. BMC Geriatr 15:40CrossRefPubMedPubMedCentral Leavy B, Byberg L, Michaelsson K, Melhus H, Aberg AC (2015) The fall descriptions and health characteristics of older adults with hip fracture: a mixed methods study. BMC Geriatr 15:40CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ et al (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA 290(13):1729–1738CrossRefPubMed Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ et al (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA 290(13):1729–1738CrossRefPubMed
35.
Zurück zum Zitat Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y (2007) Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40(6):1581–1587CrossRefPubMed Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y (2007) Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40(6):1581–1587CrossRefPubMed
36.
Zurück zum Zitat Carbone LD, Johnson KC, Bush AJ, Robbins J, Larson JC, Thomas A et al (2009) Loop diuretic use and fracture in postmenopausal women: findings from the Women’s Health Initiative. Arch Intern Med 169(2):132–140CrossRefPubMed Carbone LD, Johnson KC, Bush AJ, Robbins J, Larson JC, Thomas A et al (2009) Loop diuretic use and fracture in postmenopausal women: findings from the Women’s Health Initiative. Arch Intern Med 169(2):132–140CrossRefPubMed
37.
Zurück zum Zitat Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18(4):479–486CrossRefPubMed Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18(4):479–486CrossRefPubMed
38.
Zurück zum Zitat Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81(12):4278–4289PubMed Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81(12):4278–4289PubMed
39.
Zurück zum Zitat Ioannidis G, Pallan S, Papaioannou A, Mulgund M, Rios L, Ma J et al (2014) Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos 9(1):1–8CrossRef Ioannidis G, Pallan S, Papaioannou A, Mulgund M, Rios L, Ma J et al (2014) Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos 9(1):1–8CrossRef
40.
Zurück zum Zitat Fernández-Real J-M, López-Bermejo A, Castro A, Broch M, Peñarroja G, Vendrell J et al (2005) Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects. Thromb Haemost 94(3):615–619PubMed Fernández-Real J-M, López-Bermejo A, Castro A, Broch M, Peñarroja G, Vendrell J et al (2005) Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects. Thromb Haemost 94(3):615–619PubMed
41.
Zurück zum Zitat R Core Team (2008) R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. ISBN 3-900051-07-0, URL http://www.Rproject.org R Core Team (2008) R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. ISBN 3-900051-07-0, URL http://​www.​Rproject.​org
42.
Zurück zum Zitat Johnson GB, Riggs BL, Platt JL (2004) A genetic basis for the “Adonis” phenotype of low adiposity and strong bones. FASEB J 18(11):1282PubMed Johnson GB, Riggs BL, Platt JL (2004) A genetic basis for the “Adonis” phenotype of low adiposity and strong bones. FASEB J 18(11):1282PubMed
43.
Zurück zum Zitat Hopwood B, Tsykin A, Findlay DM, Fazzalari NL (2009) Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 44(1):87CrossRefPubMed Hopwood B, Tsykin A, Findlay DM, Fazzalari NL (2009) Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 44(1):87CrossRefPubMed
44.
Zurück zum Zitat Nose M, Yamazaki H, Hagino H, Morio Y, Hayashi S-I, Teshima R (2009) Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients. J Bone Miner Metab 27(1):57CrossRefPubMed Nose M, Yamazaki H, Hagino H, Morio Y, Hayashi S-I, Teshima R (2009) Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients. J Bone Miner Metab 27(1):57CrossRefPubMed
45.
Zurück zum Zitat D’Amelio P, Grimaldi A, Di Bella S, Tamone C, Brianza SZM, Ravazzoli MGA et al (2008) Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women. J Bone Miner Res 23(3):373CrossRefPubMed D’Amelio P, Grimaldi A, Di Bella S, Tamone C, Brianza SZM, Ravazzoli MGA et al (2008) Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women. J Bone Miner Res 23(3):373CrossRefPubMed
46.
Zurück zum Zitat Levy BT, Ritchie JM, Smith E, Gray T, Zhang W (2003) Physician specialty is significantly associated with hormone replacement therapy use. Obstet Gynecol 101(1):114–122PubMed Levy BT, Ritchie JM, Smith E, Gray T, Zhang W (2003) Physician specialty is significantly associated with hormone replacement therapy use. Obstet Gynecol 101(1):114–122PubMed
47.
Zurück zum Zitat Kodama M, Takahashi H, Iwagaki H, Itoh H, Morichika T, Yoshida A et al (2002) Effect of steroids on lipopolysaccharide/interleukin 2-induced interleukin 18 production in peripheral blood mononuclear cells. J Int Med Res 30(2):144–160CrossRefPubMed Kodama M, Takahashi H, Iwagaki H, Itoh H, Morichika T, Yoshida A et al (2002) Effect of steroids on lipopolysaccharide/interleukin 2-induced interleukin 18 production in peripheral blood mononuclear cells. J Int Med Res 30(2):144–160CrossRefPubMed
48.
Zurück zum Zitat Markofski MM, Carrillo AE, Timmerman KL, Jennings K, Coen PM, Pence BD et al (2014) Exercise training modifies ghrelin and adiponectin concentrations and is related to inflammation in older adults. J Gerontol A-Biol Sci Med Sci 69(6):675–681CrossRefPubMedPubMedCentral Markofski MM, Carrillo AE, Timmerman KL, Jennings K, Coen PM, Pence BD et al (2014) Exercise training modifies ghrelin and adiponectin concentrations and is related to inflammation in older adults. J Gerontol A-Biol Sci Med Sci 69(6):675–681CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Bell NH, Williamson BT, Hollis BW, Riggs BL (2001) Effects of race on diurnal patterns of renal conservation of calcium and bone resorption in premenopausal women. Osteoporos Int 12(1):43–48CrossRefPubMed Bell NH, Williamson BT, Hollis BW, Riggs BL (2001) Effects of race on diurnal patterns of renal conservation of calcium and bone resorption in premenopausal women. Osteoporos Int 12(1):43–48CrossRefPubMed
50.
Zurück zum Zitat Finkelstein JS, Sowers M, Greendale GA, Lee M-LT, Neer RM, Cauley JA et al (2002) Ethnic variation in bone turnover in pre-and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 87(7):3051–3056CrossRefPubMed Finkelstein JS, Sowers M, Greendale GA, Lee M-LT, Neer RM, Cauley JA et al (2002) Ethnic variation in bone turnover in pre-and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 87(7):3051–3056CrossRefPubMed
51.
Zurück zum Zitat Sowers MR, Zheng H, Greendale GA, Neer RM, Cauley JA, Ellis J et al (2013) Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab 98(7):2854–2863CrossRefPubMedPubMedCentral Sowers MR, Zheng H, Greendale GA, Neer RM, Cauley JA, Ellis J et al (2013) Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab 98(7):2854–2863CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11(10):1531–1538CrossRefPubMed Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11(10):1531–1538CrossRefPubMed
53.
Zurück zum Zitat Johansson H, Odén A, Kanis JA, McCloskey EV, Morris HA, Cooper C et al (2014) A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int 94(5):560–567CrossRefPubMed Johansson H, Odén A, Kanis JA, McCloskey EV, Morris HA, Cooper C et al (2014) A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int 94(5):560–567CrossRefPubMed
54.
Zurück zum Zitat Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC et al (2005) Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165(14):1612–1617CrossRefPubMed Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC et al (2005) Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165(14):1612–1617CrossRefPubMed
55.
Zurück zum Zitat Janghorbani M, Feskanich D, Willett WC, Hu F (2006) Prospective study of diabetes and risk of hip fracture the nurses’ health study. Diabetes Care 29(7):1573–1578CrossRefPubMed Janghorbani M, Feskanich D, Willett WC, Hu F (2006) Prospective study of diabetes and risk of hip fracture the nurses’ health study. Diabetes Care 29(7):1573–1578CrossRefPubMed
56.
Zurück zum Zitat Yu EW, Putman MS, Derrico N, Abrishamanian-Garcia G, Finkelstein JS, Bouxsein ML (2014) Defects in cortical microarchitecture among African-American women with type 2 diabetes. Osteoporos Int 1–7 Yu EW, Putman MS, Derrico N, Abrishamanian-Garcia G, Finkelstein JS, Bouxsein ML (2014) Defects in cortical microarchitecture among African-American women with type 2 diabetes. Osteoporos Int 1–7
57.
Zurück zum Zitat Barbour KE, Lui LY, Ensrud KE, Hillier TA, LeBlanc ES, Steven W et al (2014) Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res 29(9):2057–2064CrossRefPubMedPubMedCentral Barbour KE, Lui LY, Ensrud KE, Hillier TA, LeBlanc ES, Steven W et al (2014) Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res 29(9):2057–2064CrossRefPubMedPubMedCentral
Metadaten
Titel
Soluble CD14 and fracture risk
verfasst von
M. Bethel
P. Bůžková
H. A. Fink
J. A. Robbins
J. A. Cauley
J. Lee
J. I. Barzilay
D. I. Jalal
L. D. Carbone
Publikationsdatum
11.12.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 5/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3439-9

Weitere Artikel der Ausgabe 5/2016

Osteoporosis International 5/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.